Florinef, Tabletten

7680310950184 CH-31095 Tabletten
Florinef, Tabletten
Florinef, Tabletten
Florinef, Tabletten
1 / 3
google

Article details

Package size
100
Selling units
100
Measure
Tablette(n)
Galenic form
Tabletten
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
16/10/2024
Patient information leaflet
Français
16/10/2024
Patient information leaflet
Italien
16/10/2024
Summary of Product Characteristics
Allemand
16/10/2024
Summary of Product Characteristics
Français
16/10/2024
Summary of Product Characteristics
Italien
16/10/2024

Detailed composition

Substance Quantity Type Category
(N/A)
0.1 MG Substance Wirkstoff (Principe actif)
lactosum
58.922 MG Substance HBESI
calcii hydrogenophosphas dihydricus
- Substance HNIDK
maydis amylum
- Substance HNIDK
talcum
- Substance HNIDK
lactosum monohydricum
0.7 MG Substance HBESI
magnesii stearas
- Substance HNIDK
(N/A)
- Substance Konservierungsstoff (Conservateur)
natrium
0.0016 MG Substance HBESI

Reimbursement information

Public price
CHF 17.20
Specialties list
Yes
Generic
No
SL addition date: 01/11/2004

Authorization holder

Viatris Pharma GmbH

6312 Steinhausen

Authorization information

Swissmedic authorization number
31095
Drug name
Florinef, Tabletten
Galenic form
TAB
ATC Code
H02AA02
Authorization status
Z
Dispensing category
B
First authorization
05/11/1964
Authorization expiration date
31/12/9999
IT Number
07.07.3.
Domain
Human medicine
Field of application
Substitutionstherapie bei ausgeprägter NNR-Insuffizienz

Package details

Description (FR)
FLORINEF cpr 0.1 mg bte 100 pce
Description (DE)
FLORINEF Tabl 0.1 mg Ds 100 Stk
Market launch
05/11/1964
Narcotic (BTM)
No